Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Ministry of Health, Rhineland-Palatinate, Germany
Ministry of Economics, Rhineland-Palatinate, Germany
German Federal Ministry of Education and Research
Boehringer Ingelheim
Daiichi Sankyo Europe, GmbH
Sanofi
IMO Institut GmbH
PortaVita BV
The German Heart Foundation
Bayer
Information provided by (Responsible Party):
Philipp Wild, MD, MSc, Johannes Gutenberg University Mainz
ClinicalTrials.gov Identifier:
NCT01809015
First received: March 8, 2013
Last updated: May 14, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)